evans blue has been researched along with Liver Failure, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, HF; Jin, S; Liu, C; Liu, L; Liu, XD; Wang, XT; Yao, D; Zhang, M | 1 |
| Castanedes-Casey, M; Dickson, D; Eckman, CB; Genco, P; Golde, T; Lin, W; McKinney, M; Nguyen, JH; Richelson, E; Sevlever, D; Shimojima, N; Steers, J; Yamamoto, S | 1 |
2 other study(ies) available for evans blue and Liver Failure, Acute
| Article | Year |
|---|---|
P-glycoprotein and multidrug resistance-associated protein 2 are oppositely altered in brain of rats with thioacetamide-induced acute liver failure.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Blotting, Western; Brain; Evans Blue; Injections, Intraperitoneal; Liver Failure, Acute; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Permeability; Rats; Rhodamine 123; Thioacetamide; Time Factors; Vincristine | 2013 |
Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice.
Topics: Animals; Brain; Brain Edema; Capillary Permeability; Evans Blue; Liver; Liver Failure, Acute; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Up-Regulation | 2006 |